MEDICLIN Aktiengesellschaft Cash Flow Conversion Efficiency
MEDICLIN Aktiengesellschaft cash flow conversion efficiency. Based on the latest financial reports, MEDICLIN Aktiengesellschaft (MED) has a cash flow conversion efficiency ratio of 0.097x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€24.23 Million ≈ $28.33 Million USD) by net assets (€249.63 Million ≈ $291.85 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of MEDICLIN Aktiengesellschaft (2003–2025)
Cash flow conversion efficiency of MEDICLIN Aktiengesellschaft from 2003 to 2025. This chart illustrates how MEDICLIN Aktiengesellschaft's cash flow conversion efficiency has evolved over time, based on yearly financial data. View MEDICLIN Aktiengesellschaft (MED) stock price for real-time trading data and today's change.
MEDICLIN Aktiengesellschaft Cash Flow Conversion Ratio Explained
MEDICLIN Aktiengesellschaft cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
MEDICLIN Aktiengesellschaft Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of MEDICLIN Aktiengesellschaft ranked by their cash flow conversion efficiency. Also see MED market cap overview for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Tantalus Systems Holding Inc
TO:GRID
|
-0.309x |
|
Shangri-La Hotel Public Company Limited
BK:SHANG
|
0.013x |
|
Duta Intidaya Tbk PT
JK:DAYA
|
-0.595x |
|
OMS Energy Technologies Inc.
NASDAQ:OMSE
|
0.023x |
|
Sriracha Construction Public Company Limited
BK:SRICHA
|
0.699x |
|
Kafrit
TA:KAFR
|
-0.023x |
|
Asara Resources Ltd
AU:AS1
|
-0.027x |
|
Vina San Pedro
SN:VSPT
|
0.001x |
Annual Cash Flow Conversion Efficiency for MEDICLIN Aktiengesellschaft (2003–2025)
The table below shows the annual cash flow conversion efficiency of MEDICLIN Aktiengesellschaft from 2003 to 2025. Review MEDICLIN Aktiengesellschaft free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €249.63 Million ≈ $291.85 Million |
€99.87 Million ≈ $116.76 Million |
0.400x | +10.60% |
| 2024-12-31 | €222.74 Million ≈ $260.40 Million |
€80.57 Million ≈ $94.19 Million |
0.362x | -9.10% |
| 2023-12-31 | €196.03 Million ≈ $229.18 Million |
€78.00 Million ≈ $91.19 Million |
0.398x | +140.45% |
| 2022-12-31 | €209.32 Million ≈ $244.72 Million |
€34.64 Million ≈ $40.50 Million |
0.165x | -63.05% |
| 2021-12-31 | €183.02 Million ≈ $213.97 Million |
€81.97 Million ≈ $95.83 Million |
0.448x | -33.27% |
| 2020-12-31 | €176.85 Million ≈ $206.75 Million |
€118.69 Million ≈ $138.76 Million |
0.671x | +83.95% |
| 2019-12-31 | €190.75 Million ≈ $223.00 Million |
€69.59 Million ≈ $81.36 Million |
0.365x | +135.33% |
| 2018-12-31 | €191.40 Million ≈ $223.77 Million |
€29.68 Million ≈ $34.69 Million |
0.155x | +48.49% |
| 2017-12-31 | €185.26 Million ≈ $216.59 Million |
€19.34 Million ≈ $22.61 Million |
0.104x | -36.61% |
| 2016-12-31 | €181.56 Million ≈ $212.27 Million |
€29.90 Million ≈ $34.96 Million |
0.165x | -3.69% |
| 2015-12-31 | €169.14 Million ≈ $197.74 Million |
€28.92 Million ≈ $33.81 Million |
0.171x | -18.06% |
| 2014-12-31 | €153.95 Million ≈ $179.98 Million |
€32.13 Million ≈ $37.56 Million |
0.209x | +219.09% |
| 2013-12-31 | €152.19 Million ≈ $177.92 Million |
€9.95 Million ≈ $11.64 Million |
0.065x | -36.50% |
| 2012-12-31 | €157.02 Million ≈ $183.57 Million |
€16.17 Million ≈ $18.91 Million |
0.103x | +9.15% |
| 2011-12-31 | €165.59 Million ≈ $193.59 Million |
€15.63 Million ≈ $18.27 Million |
0.094x | +16.48% |
| 2010-12-31 | €164.99 Million ≈ $192.89 Million |
€13.37 Million ≈ $15.63 Million |
0.081x | -60.61% |
| 2009-12-31 | €157.26 Million ≈ $183.86 Million |
€32.35 Million ≈ $37.82 Million |
0.206x | +42.19% |
| 2008-12-31 | €148.84 Million ≈ $174.00 Million |
€21.53 Million ≈ $25.17 Million |
0.145x | -8.19% |
| 2007-12-31 | €104.17 Million ≈ $121.79 Million |
€16.41 Million ≈ $19.19 Million |
0.158x | +15.85% |
| 2006-12-31 | €98.44 Million ≈ $115.09 Million |
€13.39 Million ≈ $15.65 Million |
0.136x | -31.84% |
| 2005-12-31 | €87.83 Million ≈ $102.68 Million |
€17.52 Million ≈ $20.49 Million |
0.200x | +47.70% |
| 2004-12-31 | €81.45 Million ≈ $95.22 Million |
€11.00 Million ≈ $12.86 Million |
0.135x | +75.99% |
| 2003-12-31 | €98.80 Million ≈ $115.51 Million |
€7.58 Million ≈ $8.87 Million |
0.077x | -- |
About MEDICLIN Aktiengesellschaft
MEDICLIN Aktiengesellschaft operates hospitals in Germany. The company operates through Post-Acute; Acute; and Nursing Care and Service segments. It offers medical services in the areas of neurology; psychosomatics; orthopedics; internal medicine; cardiology; oncology; geriatrics; psychiatry; otorhinolaryngology; cardiac medicine; rheumatology; gynecology; trauma, heart, and general surgeries; ur… Read more